U
Neurothera Labs Inc. NTLX.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--

09/30/2025 09/30/2024
Total Cash And Short-Term Investments 71.00K --
Total Receivables 88.00K --
Inventory 90.00K --
Prepaid Expenses -- --
Finance Division Loans and Leases Current -- --
Total Finance Division Other Current Assets -- --
Other Current Assets 10.00K --
Total Current Assets 259.00K --

Total Current Assets 259.00K --
Net Property, Plant & Equipment -- --
Long-term Investments -- --
Goodwill -- --
Total Other Intangibles 1.34M --
Finance Div Loans & Leases LT -- --
Total Finance Div Other LT Assets -- --
Total Other Assets -- --
Total Assets 1.59M --

Total Accounts Payable 13.00K --
Total Accrued Expenses 87.00K --
Short-term Debt -- --
Current Portion of Long-Term Debt/Capital Leases -- --
Finance Division Debt Current -- --
Total Finance Division Other Current Liabilities 18.00K --
Total Other Current Liabilities 18.00K --
Total Current Liabilities 118.00K --

Total Current Liabilities 118.00K --
Long-Term Debt -- --
Short-term Debt -- --
Capital Leases -- --
Finance Division Debt Non Current -- --
Total Finance Division Other Non Current Liabilities -- --
Total Other Liabilities 202.00K --
Total Liabilities 320.00K --

Common Stock & APIC 5.56M --
Retained Earnings -4.29M --
Treasury Stock & Other -- --
Total Common Equity 1.27M --

Preferred Stock Redeemable -- --
Preferred Stock Non Redeemable -- --
Preferred Stock Convertible -- --
Preferred Stock, Others -- --
Total Preferred Equity -- --

Total Common Equity 1.27M --
Total Preferred Equity -- --
Total Minority Interest -- --
Total Equity 1.27M --